Clinical Trial Update: Tarceva With Whole Brain Radiation Therapy - Brain Mets From Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the combination of Tarceva (erlotinib) with whole brain radiation therapy for brain metastases from non-small cell lung cancer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Cancer
• Non-small Cell Lung Cancer

Drugs mentioned

• Tarceva (erlotinib)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Non-small Cell Lung Cancer, Brain Cancer | Phase 2 | Status: COMPLETED | Results posted: 2021-09-16